33,667
Views
127
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation

ORCID Icon, , , , , , , , & show all
Pages 975-989 | Received 25 Feb 2020, Accepted 19 Mar 2020, Published online: 30 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.